7-Substituted actinomycin D (NSC-3053) analogs as fluorescent DNA-binding and experimental antitumor agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001483:Base Sequence; D002474:Cell-Free System; D055598:Chemical Phenomena; D002621:Chemistry; D002875:Chromosomes; D004273:DNA, Neoplasm / Q000378:metabolism*; D003609:Dactinomycin / Q000494:pharmacology*; D005453:Fluorescence; D007778:Lactobacillus / Q000187:drug effects; D051379:Mice; D009566:Nitrates; D009574:Nitro Compounds; D009691:Nucleic Acid Denaturation; D010084:Oxidation-Reduction; D011773:Pyruvates; D014462:Ultrafiltration
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009566:Nitrates; D009574:Nitro Compounds; D011773:Pyruvates; D003609:Dactinomycin